S&P 500
(0.30%) 5 115.15 points
Dow Jones
(0.24%) 38 330 points
Nasdaq
(0.33%) 15 980 points
Oil
(-1.09%) $82.94
Gas
(4.94%) $2.02
Gold
(0.25%) $2 353.00
Silver
(0.45%) $27.66
Platinum
(3.77%) $956.90
USD/EUR
(-0.22%) $0.933
USD/NOK
(-0.34%) $10.99
USD/GBP
(-0.55%) $0.796
USD/RUB
(1.65%) $93.39

Realaus laiko atnaujinimai Shanghai Fosun [2196.HK]

Birža: HKSE Sektorius: Healthcare Pramonė: Drug Manufacturers—Specialty & Generic
Atnaujinta29 bal. 2024 @ 11:08

0.98% HKD 12.38

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 11:08):

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments...

Stats
Šios dienos apimtis 4.96M
Vidutinė apimtis 3.25M
Rinkos kapitalizacija 60.48B
EPS HKD0.186 ( 2023-09-30 )
Last Dividend HKD0.460 ( 2023-07-31 )
Next Dividend HKD0 ( N/A )
P/E 12.90
ATR14 HKD0.0150 (0.12%)

Tūris Koreliacija

Ilgas: 0.00 (neutral)
Trumpas: -0.73 (moderate negative)
Signal:(38.115) Neutral

Shanghai Fosun Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Shanghai Fosun Koreliacija - Valiuta/Žaliavos

The country flag 0.11
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.09
( neutral )
The country flag 0.56
( weak )

Shanghai Fosun Finansinės ataskaitos

Annual 2023
Pajamos: HKD41.40B
Bruto pelnas: HKD19.80B (47.84 %)
EPS: HKD0.890
FY 2023
Pajamos: HKD41.40B
Bruto pelnas: HKD19.80B (47.84 %)
EPS: HKD0.890
FY 2022
Pajamos: HKD43.95B
Bruto pelnas: HKD20.78B (47.28 %)
EPS: HKD1.430
FY 2021
Pajamos: HKD39.01B
Bruto pelnas: HKD18.78B (48.14 %)
EPS: HKD1.850

Financial Reports:

No articles found.

Shanghai Fosun Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.460
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Shanghai Fosun Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 7.35 - good (73.55%) | Divividend Growth Potential Score: 4.70 - Stable (5.98%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.210 2013-07-04
Last Dividend HKD0.460 2023-07-31
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 11 --
Total Paid Out HKD4.51 --
Avg. Dividend % Per Year 0.00% --
Score 2.42 --
Div. Sustainability Score 7.35
Div.Growth Potential Score 4.70
Div. Directional Score 6.03 --
Next Divdend (Est)
(2024-06-27)
HKD0.447 Estimate 3.11 %
Dividend Stability
0.25 Very Poor
Dividend Score
2.42
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
9989.HK Ex Dividend Junior 2023-05-24 Annually 0 0.00%
2196.HK Ex Dividend Junior 2023-07-31 Annually 0 0.00%
1203.HK Ex Dividend Junior 2023-10-03 Semi-Annually 0 0.00%
0280.HK Ex Dividend Knight 2023-09-12 Sporadic 0 0.00%
3939.HK Ex Dividend Junior 2023-06-07 Annually 0 0.00%
1776.HK Ex Dividend Junior 2023-07-11 Annually 0 0.00%
0817.HK Ex Dividend Junior 2023-09-18 Semi-Annually 0 0.00%
2359.HK Ex Dividend Knight 2023-06-05 Annually 0 0.00%
1345.HK Ex Dividend Junior 2023-10-04 Semi-Annually 0 0.00%
0390.HK Ex Dividend Junior 2023-07-19 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.05761.5008.8510.00[0 - 0.5]
returnOnAssetsTTM0.02101.2009.3010.00[0 - 0.3]
returnOnEquityTTM0.05231.500-0.530-0.795[0.1 - 1]
payoutRatioTTM1.029-1.00010.00-10.00[0 - 1]
currentRatioTTM1.0010.8009.998.00[1 - 3]
quickRatioTTM0.7570.800-0.254-0.203[0.8 - 2.5]
cashRatioTTM0.4061.5008.8610.00[0.2 - 2]
debtRatioTTM0.309-1.5004.84-7.26[0 - 0.6]
interestCoverageTTM2.501.000-0.186-0.186[3 - 30]
operatingCashFlowPerShareTTM1.1732.009.6110.00[0 - 30]
freeCashFlowPerShareTTM-0.6012.00-0.301-0.601[0 - 20]
debtEquityRatioTTM0.769-1.5006.93-10.00[0 - 2.5]
grossProfitMarginTTM0.4781.0005.365.36[0.2 - 0.8]
operatingProfitMarginTTM0.07991.000-0.402-0.402[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1001.000-0.553-0.553[0.2 - 2]
assetTurnoverTTM0.3650.800-0.901-0.721[0.5 - 2]
Total Score7.35

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM14.551.0008.630[1 - 100]
returnOnEquityTTM0.05232.50-0.341-0.795[0.1 - 1.5]
freeCashFlowPerShareTTM-0.6012.00-0.200-0.601[0 - 30]
dividendYielPercentageTTM3.981.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.1732.009.6110.00[0 - 30]
payoutRatioTTM1.0291.50010.00-10.00[0 - 1]
pegRatioTTM6.621.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.08521.000-0.3700[0.1 - 0.5]
Total Score4.70

Shanghai Fosun

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.